Lack of Period1 accelerates colorectal tumorigenesis in ApcMin/+ mice

This study demonstrates that the loss of the circadian clock gene *Per1* exacerbates colorectal tumorigenesis in *ApcMin/+* mice by increasing polyp burden and elevating β-catenin protein levels through non-transcriptional mechanisms, thereby establishing a tumor-suppressive role for *Per1*.

The Gist

Imagine your body is a bustling city that runs on a strict 24-hour schedule. Just like a city needs traffic lights, power grids, and a central clock tower to keep everything running smoothly, your cells have an internal "biological clock" called the circadian clock. This clock tells your cells when to sleep, when to eat, and when to divide (make copies of themselves).

One of the most important "gears" inside this clock is a protein called Per1. Think of Per1 as a strict security guard or a traffic cop. Its job is to make sure the city doesn't get too chaotic and that cells don't start dividing at the wrong times.

The Problem: A Broken Lock

In this study, scientists looked at what happens when this security guard (Per1) goes on vacation. They used a special type of mouse that is genetically programmed to develop colorectal cancer (tumors in the intestine). These mice have a broken "brake pedal" in their cells (a mutation in a gene called Apc), which usually leads to the growth of polyps (small lumps that can turn into cancer).

The researchers created a group of these mice that were missing the Per1 security guard entirely. They wanted to see: Does losing the clock make the cancer grow faster?

The Findings: Chaos in the City

Here is what they discovered, using some simple analogies:

1. The "Polyp" Explosion
In the mice with the broken brake pedal (Apc mutation) but with a working security guard (Per1), they grew a certain number of polyps.
However, in the mice that were missing the security guard (Apc mutation + Per1 deletion), the city went into total chaos. They grew twice as many polyps!

• Analogy: Imagine a construction site where the foreman is missing. Without the foreman to say "stop" or "slow down," the workers (cells) start building extra, unnecessary structures (polyps) everywhere, making the site a mess much faster.

2. The "Traffic Jam" of Growth Signals
The researchers looked at a specific molecule called β-catenin. You can think of β-catenin as a "Go" signal or a green light for cell growth.

• In healthy cells, this green light is turned off when it's not needed.
• In the mice missing Per1, the green light stayed stuck on ON.
• Crucial Discovery: The researchers found that the amount of the "Go" signal (the protein) was high, but the instructions to make that signal (the mRNA) were normal.
• Analogy: It's like a factory where the manager isn't ordering more products, but the machines are somehow running faster anyway. The problem isn't that they are printing more instructions; it's that the factory floor is malfunctioning and not recycling the "Go" signals properly. The Per1 guard usually helps recycle these signals, but without it, they pile up.

3. The Survival Mystery
Interestingly, even though the mice missing Per1 grew more polyps, they didn't necessarily die sooner than the other mice. In fact, their survival times were more unpredictable.

• Analogy: It's like two cars with bad brakes. One car has a working speedometer (Per1), and the other has a broken one. The car with the broken speedometer might drive faster and hit more obstacles (polyps), but it doesn't always crash immediately. It just makes the ride much more erratic and dangerous.

The Big Takeaway

This study tells us that the Per1 clock gene is a tumor suppressor. It acts like a safety net. When you lose Per1, your body loses a critical layer of defense against cancer.

Even though the mice didn't die faster in this specific experiment, the fact that they developed twice as many tumors and had accumulated "Go" signals suggests that Per1 is essential for keeping the intestinal city organized. Without it, the "construction crew" (cells) goes wild, building dangerous structures that can lead to cancer.

In short: Your body's internal clock isn't just about when you feel sleepy; it's a vital security system that stops your cells from growing out of control. When that clock breaks, the risk of cancer goes up.

Technical Summary

1. Problem Statement

The circadian clock regulates physiological processes through ~24-hour rhythms, and disruptions in core clock genes are implicated in tumorigenesis. While previous studies have suggested that clock gene defects (e.g., Per2, Bmal1) can exacerbate cancer, the specific role of Period 1 (Per1) in colorectal cancer (CRC) development remains unclear. Conflicting literature exists, with some studies suggesting Per1 loss promotes cancer and others showing no effect. This study aimed to clarify how Per1 deficiency influences the initiation and progression of colorectal tumors, specifically focusing on polyp burden, histopathology, and the molecular mechanisms involving the Wnt/β-catenin signaling pathway.

2. Methodology

The researchers utilized a genetic mouse model approach combined with multi-modal biological assays:

• Animal Models:
  • Strains: Wild-type (WT), Per1 knockout (Per1-/-), ApcMin/+ (a model for Familial Adenomatous Polyposis), and the double mutant ApcMin/+Per1-/-.
  • Background: C57BL/6J.
  • Conditions: Mice were housed under controlled 12h light/12h dark cycles. For survival analysis, mice were moved to light-tight chambers at 8 weeks.
• Experimental Groups & Endpoints:
  • Survival Analysis: Monitored daily from 8 weeks; humane endpoints set at >10% weight loss (observation) or >20% weight loss (euthanasia).
  • Polyp Counting: At 150 days, intestines were harvested, opened longitudinally, and polyps were counted and categorized by size (<2 mm vs. ≥2 mm) and location (duodenum, jejunum 1 & 2, ileum, colon).
  • Histopathology: Intestinal "Swiss-roll" sections (150-day-old mice) were prepared for H&E staining to visualize aberrant crypt foci (ACF) and polyps.
  • Protein Analysis (Western Blot): Intestinal tissues (150-day-old) were analyzed for β-catenin protein abundance.
  • Transcriptional Analysis (RT-qPCR): Intestinal tissues (120-day-old) were analyzed for Ctnnb1 (β-catenin gene) mRNA levels.
  • Proliferation Assay: BrdU immunohistochemistry was performed on 120–140-day-old mice to quantify the proportion of proliferating cells in intestinal crypts.
• Statistical Analysis: Welch's t-test for survival/polyp counts; Two-way ANOVA (factors: Per1 deficiency and Apc mutation) for molecular and proliferation data.

3. Key Contributions

• Genetic Interaction: Successfully generated and characterized the ApcMin/+Per1-/- double mutant mouse model to isolate the specific effect of Per1 loss on Apc-driven tumorigenesis.
• Mechanistic Insight: Differentiated between transcriptional and post-transcriptional regulation of β-catenin in the context of circadian gene loss.
• Regional Specificity: Provided a granular analysis of polyp distribution across different intestinal segments (duodenum to colon) rather than just total counts.

4. Key Results

• Survival:

  • Per1 deletion did not significantly alter the overall survival rate or mean survival days of ApcMin/+ mice (158 days vs. 168 days; P = 0.25).
  • However, ApcMin/+Per1-/- mice exhibited increased inter-individual variability in survival (larger standard deviation) compared to ApcMin/+ mice.

• Polyp Burden:

  • Per1 deletion caused a marked increase in total polyp number. ApcMin/+Per1-/- mice had significantly more polyps than ApcMin/+ mice (54.8 vs. 26.9; P < 0.05).
  • This increase was observed in both small (<2 mm) and large (≥2 mm) polyps.
  • The effect was consistent across all intestinal segments, including the duodenum, jejunum, ileum, and colon.

• Histopathology:

  • H&E staining confirmed the presence of aberrant crypt foci (ACF) and polyps in ApcMin/+ and ApcMin/+Per1-/- mice, while WT and Per1-/- mice showed normal architecture.
  • Immunofluorescence revealed nuclear and cytoplasmic accumulation of β-catenin in the intestinal villi and crypts of ApcMin/+Per1-/- mice, particularly near the crypts.

• Molecular Mechanisms (β-catenin Regulation):

  • Protein Levels: Western blotting showed a significant increase in β-catenin protein levels in the whole intestine of ApcMin/+Per1-/- mice compared to ApcMin/+ mice. Both Per1 deficiency and Apc mutation were significant factors increasing protein levels.
  • mRNA Levels: RT-qPCR revealed that Ctnnb1 mRNA levels did not significantly change in response to Per1 deletion.
  • Conclusion on Mechanism: The increase in β-catenin protein is driven by non-transcriptional mechanisms (likely post-translational stabilization or reduced degradation) rather than increased gene transcription.

• Cell Proliferation:

  • BrdU labeling showed that the Apc mutation significantly increased crypt cell proliferation.
  • However, Per1 deletion did not significantly further increase the proportion of proliferating cells, suggesting the increased polyp burden is not solely due to a generalized increase in the proliferation rate of crypt cells.

5. Significance

• Tumor Suppressor Role: The study confirms that Per1 acts as a tumor suppressor in colorectal cancer. Its loss accelerates tumorigenesis by increasing polyp burden in an Apc-mutant background.
• Novel Regulatory Pathway: The findings suggest that Per1 regulates β-catenin abundance via post-transcriptional mechanisms. Since Ctnnb1 mRNA levels remained stable while protein levels rose, Per1 likely influences the stability, degradation, or subcellular localization of β-catenin protein, rather than its synthesis.
• Clinical Relevance: Given the high prevalence of circadian disruption in modern society and the known link between clock genes and cancer, these results highlight Per1 as a potential critical factor in the progression of familial adenomatous polyposis and sporadic colorectal cancer.
• Future Directions: The authors propose that future research should investigate β-catenin phosphorylation status, subcellular localization, and specific components of the degradation machinery to fully elucidate the non-transcriptional mechanism identified.